Market overview
The global microbial coagulants market is worth USD 504 mn in 2026 and is forecast to reach USD 821 mn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Fermentation-produced chymosin is the largest by source segment.
| Scope | Enzymes produced by microbial fermentation or fungi that curdle milk for cheese making, replacing calf rennet, including fermentation-produced chymosin and fungal coagulants. |
|---|---|
| Industry | Food and Beverage |
| Value 2025 | USD 480 mn |
| Value 2026 | USD 504 mn |
| Value 2036 | USD 821 mn |
| CAGR 2026-2036 | 5.0% |
| Volume 2026 | 41.8 million litres |
| Volume 2036 | 64.8 million litres |
| Average price 2026 | USD 12.1 per litre |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Microbial Coagulants market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 504 mn |
| 2027 | USD 529 mn |
| 2028 | USD 556 mn |
| 2029 | USD 583 mn |
| 2030 | USD 613 mn |
| 2031 | USD 643 mn |
| 2032 | USD 675 mn |
| 2033 | USD 709 mn |
| 2034 | USD 745 mn |
| 2035 | USD 782 mn |
| 2036 | USD 821 mn |
Microbial Coagulants market segmentation
By source
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fermentation-produced chymosin | 55.0% | 58.1% | USD 277 mn | 5.6% |
| Fungal coagulants | 30.0% | 27.5% | USD 151 mn | 4.1% |
| Other microbial | 15.0% | 14.4% | USD 76 mn | 4.6% |
By cheese type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hard and semi-hard | 40.0% | 38.7% | USD 202 mn | 4.6% |
| Mozzarella and pasta filata | 25.0% | 26.6% | USD 126 mn | 5.6% |
| Soft and fresh | 20.0% | 20.3% | USD 101 mn | 5.1% |
| Processed and other | 15.0% | 14.5% | USD 76 mn | 4.6% |
By form
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Liquid | 62.0% | 59.0% | USD 312 mn | 4.5% |
| Powder | 26.0% | 27.0% | USD 131 mn | 5.4% |
| Tablets | 12.0% | 14.0% | USD 60 mn | 6.6% |
By dairy scale
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Large industrial dairies | 52.0% | 51.0% | USD 262 mn | 4.8% |
| Mid-size dairies | 30.0% | 30.0% | USD 151 mn | 5.0% |
| Artisan and farmhouse makers | 18.0% | 19.0% | USD 91 mn | 5.6% |
By dietary suitability
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vegetarian | 56.0% | 54.0% | USD 282 mn | 4.6% |
| Kosher and halal certified | 30.0% | 31.0% | USD 151 mn | 5.3% |
| Non-GMO and organic compatible | 14.0% | 15.0% | USD 71 mn | 5.7% |
Top 25 countries for microbial coagulants by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 69.5% of 2026 revenue and the 25 countries below together hold 92.1%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 101 mn | 20.0% | USD 159 mn | 4.7% |
| 2 | Germany | USD 40 mn | 8.0% | USD 61 mn | 4.2% |
| 3 | France | USD 35 mn | 7.0% | USD 53 mn | 4.2% |
| 4 | Italy | USD 35 mn | 7.0% | USD 53 mn | 4.2% |
| 5 | China | USD 30 mn | 6.0% | USD 66 mn | 8.2% |
| 6 | Netherlands | USD 25 mn | 5.0% | USD 38 mn | 4.1% |
| 7 | United Kingdom | USD 25 mn | 5.0% | USD 38 mn | 4.1% |
| 8 | Brazil | USD 20 mn | 4.0% | USD 37 mn | 6.2% |
| 9 | Poland | USD 20 mn | 4.0% | USD 34 mn | 5.3% |
| 10 | Canada | USD 18 mn | 3.5% | USD 28 mn | 4.7% |
| 11 | Spain | USD 18 mn | 3.5% | USD 27 mn | 4.5% |
| 12 | Ireland | USD 13 mn | 2.5% | USD 19 mn | 4.5% |
| 13 | Denmark | USD 10 mn | 2.0% | USD 16 mn | 4.5% |
| 14 | Switzerland | USD 8.9 mn | 1.8% | USD 14 mn | 4.5% |
| 15 | Austria | USD 8.0 mn | 1.6% | USD 12 mn | 4.5% |
| 16 | Belgium | USD 7.3 mn | 1.4% | USD 11 mn | 4.5% |
| 17 | New Zealand | USD 6.7 mn | 1.3% | USD 10 mn | 4.5% |
| 18 | Australia | USD 6.3 mn | 1.2% | USD 9.7 mn | 4.4% |
| 19 | Argentina | USD 5.9 mn | 1.2% | USD 9.2 mn | 4.5% |
| 20 | Mexico | USD 5.6 mn | 1.1% | USD 11 mn | 7.2% |
| 21 | Turkey | USD 5.3 mn | 1.1% | USD 11 mn | 7.1% |
| 22 | Russia | USD 5.1 mn | 1.0% | USD 6.8 mn | 2.9% |
| 23 | Egypt | USD 4.9 mn | 1.0% | USD 9.8 mn | 7.1% |
| 24 | India | USD 4.7 mn | 0.9% | USD 12 mn | 9.5% |
| 25 | South Korea | USD 4.6 mn | 0.9% | USD 9.1 mn | 7.1% |
| Rest of world | USD 40 mn | 7.9% | USD 65 mn | 5.0% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Novonesis
- dsm-firmenich
Group 2: Regional and specialist players
- Meito Sangyo
- CSK Food Enrichment
- Clerici-Sacco Group
- Amano Enzyme
- Biocatalysts
- Sacco System
- AB Enzymes
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the microbial coagulants market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.
The market is divided by source, by cheese type, by form, by dairy scale, by dietary suitability. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the microbial coagulants market?
The global microbial coagulants market is estimated at USD 480 mn in 2025 and USD 504 mn in 2026.
How fast will the microbial coagulants market grow?
It is forecast to reach USD 821 mn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 317 mn.
Which country is the largest market for microbial coagulants?
United States is the largest market by revenue at USD 101 mn in 2026, 20.0% of the global total. The three largest countries together hold 35.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.2% a year from 2026 to 2036.
Which microbial coagulants segment is largest?
In the by source split, Fermentation-produced chymosin is the largest segment with 55.0% of 2026 revenue.
Who are the leading microbial coagulants companies?
Global leaders include Novonesis, dsm-firmenich.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Food and Beverage
- Broad Spectrum CBD GummiesUSD 504 mn · 5.5% CAGR
- Clean-Label Smoke Flavor AlternativesUSD 506 mn · 5.6% CAGR
- Functional Fruit LeathersUSD 502 mn · 4.7% CAGR
- Apple FrittersUSD 497 mn · 3.6% CAGR
- NAD Precursor SupplementsUSD 495 mn · 9.0% CAGR
- Dough Dividers & RoundersUSD 483 mn · 5.2% CAGR
- MycoproteinUSD 483 mn · 14.0% CAGR
- Sourdough Fermentation SystemsUSD 528 mn · 5.5% CAGR
← Methane-Reducing Feed Additive Microparticulated Whey Protein →